Author's reply to "Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer".
Saved in:
| Title: | Author's reply to "Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer". |
|---|---|
| Authors: | Kano S; Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, N15, W7, Kita-ku, Sapporo, 060-8638, Japan., Kinoshita I; Department of Medical Oncology, Hokkaido University Hospital, N14, W5, Kita-ku, Sapporo, 060-8648, Japan., Dosaka-Akita H; Department of Medical Oncology, Hokkaido University Hospital, N14, W5, Kita-ku, Sapporo, 060-8648, Japan. |
| Source: | Japanese journal of clinical oncology [Jpn J Clin Oncol] 2025 Nov 08; Vol. 55 (11), pp. 1298. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0313225 Publication Model: Print Cited Medium: Internet ISSN: 1465-3621 (Electronic) Linking ISSN: 03682811 NLM ISO Abbreviation: Jpn J Clin Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40888807 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author's reply to "Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer". – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kano+S%22">Kano S</searchLink>; Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, N15, W7, Kita-ku, Sapporo, 060-8638, Japan.<br /><searchLink fieldCode="AU" term="%22Kinoshita+I%22">Kinoshita I</searchLink>; Department of Medical Oncology, Hokkaido University Hospital, N14, W5, Kita-ku, Sapporo, 060-8648, Japan.<br /><searchLink fieldCode="AU" term="%22Dosaka-Akita+H%22">Dosaka-Akita H</searchLink>; Department of Medical Oncology, Hokkaido University Hospital, N14, W5, Kita-ku, Sapporo, 060-8648, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220313225%22">Japanese journal of clinical oncology</searchLink> [Jpn J Clin Oncol] 2025 Nov 08; Vol. 55 (11), pp. 1298. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0313225 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1465-3621 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203682811%22">03682811 </searchLink><i>NLM ISO Abbreviation: </i>Jpn J Clin Oncol <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40888807 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/jjco/hyaf138 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1298 Titles: – TitleFull: Author's reply to "Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer". Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kano S – PersonEntity: Name: NameFull: Kinoshita I – PersonEntity: Name: NameFull: Dosaka-Akita H IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 11 Text: 2025 Nov 08 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1465-3621 Numbering: – Type: volume Value: 55 – Type: issue Value: 11 Titles: – TitleFull: Japanese journal of clinical oncology Type: main |
| ResultId | 1 |
